Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDX Holdings appoints new non-executive vice-chairman

This article was originally published in Scrip

Executive Summary

CDX Holdings, the parent company of Caris Diagnostics (Caris Dx) and Caris Molecular Diagnostics (CMDx), has appointed Dr George Poste non-executive vice-chairman and chief scientific advisor, and has also made him non-executive chairman of CMDx. Dr Poste has previously led research programmes in biotechnology, nanotechnology, materials science and advanced computing at Arizona State University and has served as chairman of the task force on bioterrorism for the US Department of Defense, where he also serves as a member of the Defense Science Board. He is also a member of the Institute of MedicineBoard of Global Health.

Topics

UsernamePublicRestriction

Register

SC003254

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel